← Back to Search

Probiotic

Holter Monitor for Multiple Primary Cancers

N/A
Waitlist Available
Led By An T. Ngo-Huang
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 days
Awards & highlights

Study Summary

This trial will test whether eating yogurt with probiotics can help ease gastrointestinal symptoms in cancer patients. Researchers will also study whether the bacteria in patients' stool changes as their symptoms change.

Eligible Conditions
  • Multiple Primary Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage Change in Bacteroidetes in Stool from Baseline to Day 12
Percentage Change in Firmicutes in Stool from Baseline to Day 12
Secondary outcome measures
Adherence Rate of Dannon® Oikos® Yogurt Intake

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group 2 - No Antibiotics Taken During Past 2 WeeksExperimental Treatment5 Interventions
Group 2: Participant has not been on antibiotics in the past 2 weeks. Tongue assessment, stool sample, and questionnaires done at baseline and once during Days 3-7 and once during Days 8-12. Participants wear a Holter monitor for 20-24 hours at baseline and once during Days 3-7 and once during Days 8-12. Participants given 2 tablespoons (33 cc) of yogurt each day for 12 days.
Group II: Group 1 - Antibiotics Taken During Past 2 WeeksExperimental Treatment5 Interventions
Group 1: Participant was on antibiotics anytime during the past 2 weeks prior to the time of enrollment. Tongue assessment, stool sample, and questionnaires done at baseline and once during Days 3-7 and once during Days 8-12. Participants wear a Holter monitor for 20-24 hours at baseline and once during Days 3-7 and once during Days 8-12. Participants given 2 tablespoons (33 cc) of yogurt each day for 12 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Holter Monitor
2020
N/A
~10
Questionnaires
2013
Completed Phase 2
~3330

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,966 Previous Clinical Trials
1,804,848 Total Patients Enrolled
An T. Ngo-HuangPrincipal InvestigatorM.D. Anderson Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in this clinical experiment for participants?

"The latest update on clinicaltrials.gov indicates that the study, which was initially posted in March of 2023, is not presently looking for participants. However, there are 2,381 other ongoing trials searching for volunteers at this time."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms
2022. "The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03177681.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top